|
1
|
Igaz P, Toth S and Falus A: Biological and
clinical significance of the JAK-STAT pathway; lessons from
knockout mice. Inflamm Res. 50:435–441. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kisseleva T, Bhattacharya S, Braunstein J
and Schindler CW: Signaling through the JAK/STAT pathway, recent
advances and future challenges. Gene. 285:1–24. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sen R and Baltimore D: Multiple nuclear
factors interact with the immunoglobulin enhancer sequences. Cell.
46:705–716. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeh CH, Chen TP, Wu YC, Lin YM and Jing
Lin P: Inhibition of NFkappaB activation with curcumin attenuates
plasma inflammatory cytokines surge and cardiomyocytic apoptosis
following cardiac ischemia/reperfusion. J Surg Res. 125:109–116.
2005. View Article : Google Scholar
|
|
5
|
Altavilla D, Deodato B, Campo GM, et al:
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits
activation of nuclear factor-kappaB and reduces the inflammatory
response in myocardial ischemia-reperfusion injury. Cardiovasc Res.
47:515–528. 2000. View Article : Google Scholar
|
|
6
|
Christman JW, Lancaster LH and Blackwell
TS: Nuclear factor kappa B: a pivotal role in the systemic
inflammatory response syndrome and new target for therapy.
Intensive Care Med. 24:1131–1138. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen J, Jiang H, Yang J, Chen SS and Xu L:
Down-regulation of CREB-binding protein expression blocks
thrombin-mediated endothelial activation by inhibiting acetylation
of NF-kappaB. Int J Cardiol. 154:147–152. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan Y, Wang J, Wei L, He B, Wang C and
Wang B: Iron deficiency activates pro-inflammatory signaling in
macrophages and foam cells via the p38 MAPK-NF-kappaB pathway. Int
J Cardiol. 152:49–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang S, He B, Goldstein S, Ge J, Wang Z
and Ruiz G: Changes in adiponectin expression in acute myocardial
infarction rats and the significance of bisoprolol intervention.
Can J Physiol Pharmacol. 89:109–115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang S, He B, Ge J, Zhai C, Liu X and Liu
P: Characterization of chemical composition of Agaricus
brasiliensis polysaccharides and its effect on myocardial SOD
activity, MDA and caspase-3 level in ischemia-reperfusion rats. Int
J Biol Macromol. 46:363–366. 2010.PubMed/NCBI
|
|
11
|
Zhang S, He B, Ge J, et al: Extraction,
chemical analysis of Angelica sinensis polysaccharides and
antioxidant activity of the polysaccharides in ischemia-reperfusion
rats. Int J Biol Macromol. 47:546–550. 2010.PubMed/NCBI
|
|
12
|
Booz GW, Day JN and Baker KM: Interplay
between the cardiac renin angiotensin system and JAK-STAT
signaling: role in cardiac hypertrophy, ischemia/reperfusion
dysfunction, and heart failure. J Mol Cell Cardiol. 34:1443–1453.
2002. View Article : Google Scholar
|
|
13
|
Strutz F and Muller GA: The role of
tubulo-interstitial processes in progression of primary renal
diseases. Nephr Dial Transplant. 9:10–20. 1994. View Article : Google Scholar
|
|
14
|
Boengler K, Hilfiker-Kleiner D, Drexler H,
Heusch G and Schulz R: The myocardial JAK/STAT pathway: from
protection to failure. Pharmacol Ther. 120:172–185. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Negoro S, Kunisada K, Tone E, et al:
Activation of JAK/STAT pathway transduces cytoprotective signal in
rat acute myocardial infarction. Cardiovasc Res. 47:797–805. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mascareno E, El-Shafei M, Maulik N, et al:
JAK/STAT signaling is associated with cardiac dysfunction during
ischemia and reperfusion. Circulation. 104:325–329. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heyninck K, Kreike MM and Beyaert R:
Structure-function analysis of the A20-binding inhibitor of
NF-kappa B activation, ABIN-1. FEBS Lett. 536:135–140. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nair A, Venkatraman M, Maliekal TT, Nair B
and Karunagaran D: NF-kappaB is constitutively activated in
high-grade squamous intraepithelial lesions and squamous cell
carcinomas of the human uterine cervix. Oncogene. 22:50–58. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sen R and Baltimore D: Inducibility of
kappa immunoglobulin enhancer-binding protein Nf-kappa B by a
posttranslational mechanism. Cell. 47:921–928. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pahl HL: Activators and target genes of
Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodriguez-Porcel M, Lerman LO, Holmes DR
Jr, Richardson D, Napoli C and Lerman A: Chronic antioxidant
supplementation attenuates nuclear factor-kappa B activation and
preserves endothelial function in hypercholesterolemic pigs.
Cardiovasc Res. 53:1010–1018. 2002. View Article : Google Scholar
|
|
22
|
Dichtl W, Nilsson L, Goncalves I, et al:
Very low-density lipoprotein activates nuclear factor-kappaB in
endothelial cells. Circ Res. 84:1085–1094. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ritchie ME: Nuclear factor-kappaB is
selectively and markedly activated in humans with unstable angina
pectoris. Circulation. 98:1707–1713. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawano S, Kubota T, Monden Y, et al:
Blockade of NF-kappaB improves cardiac function and survival after
myocardial infarction. Am J Physiol Heart Circ Physiol.
291:H1337–H1344. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carswell EA, Old LJ, Kassel RL, Green S,
Fiore N and Williamson B: An endotoxin-induced serum factor that
causes necrosis of tumors. Proc Natl Acad Sci U S A. 72:3666–3670.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shaw T, Nixon JS and Bottomley KM:
Metalloproteinase inhibitors: new opportunities for the treatment
of rheumatoid arthritis and osteoarthritis. Expert Opin Investig
Drugs. 9:1469–1478. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang NL, Chiang SH, Hsueh CH, Liang YJ,
Chen YJ and Lai LP: Metformin inhibits TNF-alpha-induced IkappaB
kinase phosphorylation, IkappaB-alpha degradation and IL-6
production in endothelial cells through PI3K-dependent AMPK
phosphorylation. Int J Cardiol. 134:169–175. 2009. View Article : Google Scholar
|
|
28
|
Cao YL, Wang YX, Wang DF, Meng X and Zhang
J: Correlation between omental TNF-alpha protein and plasma PAI-1
in obesity subjects. Int J Cardiol. 128:399–405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Conraads VM, Denollet J, De Clerck LS,
Stevens WJ, Bridts C and Vrints CJ: Type D personality is
associated with increased levels of tumour necrosis factor
(TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int J
Cardiol. 113:34–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sharma R and Anker SD: Cytokines,
apoptosis and cachexia: the potential for TNF antagonism. Int J
Cardiol. 85:161–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ridker PM, Rifai N, Pfeffer M, Sacks F,
Lepage S and Braunwald E: Elevation of tumor necrosis factor-alpha
and increased risk of recurrent coronary events after myocardial
infarction. Circulation. 101:2149–2153. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Irwin MW, Mak S, Mann DL, et al: Tissue
expression and immunolocalization of tumor necrosis factor-alpha in
postinfarction dysfunctional myocardium. Circulation. 99:1492–1498.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Held TK, Weihua X, Yuan L, Kalvakolanu DV
and Cross AS: Gamma interferon augments macrophage activation by
lipopolysaccharide by two distinct mechanisms, at the signal
transduction level and via an autocrine mechanism involving tumor
necrosis factor alpha and interleukin-1. Infect Immun. 67:206–212.
1999.
|
